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Background: East Asian countries have high suicide rates. However, little is known about clinical and
sociodemographic factors associated with suicidality in Asian populations. The aim of this study was to evaluate the
factors associated with suicidality in patients with major depressive disorder (MDD) from six Asian countries.
Methods: The study cohort consisted of 547 outpatients with MDD. Patients presented to study sites in China
(n = 114), South Korea (n = 101), Malaysia (n = 90), Singapore (n = 40), Thailand (n = 103), and Taiwan (n = 99). All
patients completed the Mini-International Neuropsychiatric Interview (MINI), the Montgomery–Asberg Depression
Rating Scale (MADRS), the Global Severity Index(SCL-90R), the Fatigue Severity Scale, the 36-item short-form health
survey, the Sheehan Disability Scale, and the Multidimensional Scale of Perceived Social Support (MSPSS). Patients
were classified as showing high suicidality if they scored ≥6 on the MINI suicidality module. Multivariate logistic
regression analysis was used to examine sociodemographic and clinical factors related to high suicidality.
Results: One hundred and twenty-five patients were classed as high suicidality. Unemployed status (adjusted odds
ratio [OR] 2.43, p < 0.01), MADRS score (adjusted OR 1.08), p < 0.001, and GSI (SCL-90R) score (adjusted OR 1.06,
p < 0.01) were positively related to high suicidality. Hindu (adjusted OR 0.09, p < 0.05) or Muslim (adjusted OR 0.21,
p < 0.001) religion and MSPSS score (adjusted OR 0.82, p < 0.05) were protective against high suicidality.
Conclusions: A variety of sociodemographic and clinical factors were associated with high suicidality in Asian
patients with MDD. These factors may facilitate the identification of MDD patients at risk of suicide.
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It is estimated that approximately 1 million people world-
wide commit suicide annually, and about 60% of these
people are from Asian countries [1,2]. The suicide rate in
East Asian countries, including South Korea, Japan, and
China, is especially high. According to a 2011 report from
the World Health Organization’s worldwide initiative for
the prevention of suicide, Korea ranked third, Japan
ranked ninth, and China ranked twenty-fourth out of 105
countries for suicide rate [3]. Despite such compelling fig-
ures, suicide is relatively under-researched, and preventive* Correspondence: jphong@amc.seoul.kr
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unless otherwise stated.approaches in Asian countries are limited compared to
those in European and American countries [4-6].
Studies have consistently reported that major depres-
sive disorder (MDD) is closely related to suicide, suicidal
ideation, suicide planning, and suicide attempts and is a
significant risk factor for suicide [7,8]. According to pre-
vious studies, severe or extended depression [9-12], ad-
vanced age [9], low level of education [13], low level of
social support and occupational functioning [9,11], lack
of a partner [11,12], current alcohol dependence or sub-
stance abuse [9,11,13], negative life events [14], and im-
pulsivity and hostility [10,15,16] have all been reported
to be risk factors for suicide attempts in MDD. However,
the etiology of MDD is extremely complicated, and the
generalization of suicide risk factors is difficult because. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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and the methods employed. In particular, the profiles of
risk and protective factors of suicide in Asian countries
differ from those of Western countries [10].
Recently, we reported that melancholic features and
hostility were associated with suicidal risk in MDD pa-
tients from six Asian countries [17]. However, the cited
study mainly focused on melancholic features and did
not examine important factors such as religion, func-
tional impairment, and poor social support. Interest-
ingly, the prevalence of MDD is lower in East Asian
countries than in European and American countries, but
suicide rates are higher [18,19]. This suggests that in
East Asian countries, various clinical, social, and cultural
factors, including religious practices, may be related to
suicide in addition to psychiatric disorders such as MDD.
Although several studies have provided information on
the risk factors for suicide in Asian countries [20-22],
comprehensive examination on the characteristics of sui-
cide in MDD by multi-country comparative analysis was
few. Accordingly, the aim of the present study was to
evaluate the sociodemographic and clinical factors related
to suicidality in MDD patients from six Asian countries
(China, South Korea, Malaysia, Singapore, Taiwan, and
Thailand).Methods
Study design and settings
This study uses data from the Study on the Aspects of
Asian Depression (SAAD) [20]. The participants and
method of the present study are the same as those of the
Recognizing Ethnic Differences in Depression (REDD)
study [17], a multi-country, cross-sectional, observa-
tional study of depression in clinical settings carried out
during 2008–2011. Thirteen study sites were established
across six Asian countries: China, South Korea, Malaysia,
Singapore, Taiwan, and Thailand. The study sites were as
follows: Beijing Anding Hospital (Beijing, China), Institute
of Mental Health (Beijing, China), Shanghai Mental
Health Center (Shanghai, China), Samsung Medical Cen-
ter (Seoul, Korea), Asan Medical Center (Seoul, Korea),
Kyungpook National University Hospital (Daegu, Korea),
Inha University Hospital (Incheon, Korea), University of
Malaya Medical Center (Kuala Lumpur, Malaysia), Insti-
tute of Mental Health Woodbridge Hospital (Singapore),
Chung Gang Memorial Hospital (Taoyan county, Taiwan),
McKay Memorial Hospital (Taipei City, Taiwan), Maharaj
Nakorn Chiang Mai Hospital (Chiang Mai, Thailand), and
Prince of Songkla University (Songkla, Thailand). All study
sites provided psychiatric care for the public or private
sector. The study was approved by the Institutional Re-
view Board or Ethics Committee of Asan Medical Center
and each respective site.Participants
Participants were prospectively enrolled in the study and
were recruited from outpatients who were seeking psychi-
atric treatment at a study site. Individuals presenting for
an intake appointment were approached by a study coord-
inator and informed about the study. After the study de-
tails had been fully explained, written informed consent
was obtained from each participant. The inclusion criteria
were as follows: i) age 18–65 years; ii) a positive response
(“yes”) to the Mini-International Neuropsychiatric Inter-
view (MINI) [21] question A1 (depressed mood) and/or
A2 (loss of interest); and iii) a diagnosis of MDD accord-
ing to the DSM-IV criteria [22] that was assessed by the
MINI. The exclusion criteria were as follows: i) unstable
medical condition; ii) mood disorder due to medical con-
ditions and/or substance abuse; iii) psychotic or bipolar
disorder; iv) clinically significant cognitive impairment; v)
treatment with psychotropic medication within the previ-
ous month; vi) treatment with a benzodiazepine within
the previous week; and vii) treatment with a long-acting
antipsychotic medication within the previous 3 months.
All other psychiatric and comorbid conditions were
permitted.
The following sociodemographic characteristics were
recorded: age, sex, marital status (married or co-habiting;
widowed or divorced; never married), work status
(employed; homemaker or student; unemployed), and
education (none or primary; secondary or vocational;
college). The following clinical characteristics were re-
corded: age at first onset, length of illness, number of past
psychiatric hospitalizations, and depression severity.
Assessment
Participants completed several self-report questionnaires
in the presence of the study coordinator. A face-to-face
diagnostic evaluation was then conducted with the site
investigator before the participant met with their treat-
ing clinician. Data collection was accomplished in a sin-
gle visit. Suicidality is the likelihood of an individual
completing suicide and include suicidal ideation, self-
injurious behavior, suicide attempts, and suicide despite
their very different consequences for the patient. In the
present study, the term “suicidality” includes the full
spectrum of suicidal thoughts (thoughts about wanting
to be dead) and suicidal acts (previous self-destructive
behaviors [23] with at least some intent to end one’s
life), in keeping with a previous study [23].
Suicidal ideation and behaviors were assessed with the
MINI suicidality module [21]. The MINI suicidality
module was used to rate the risk of suicide. The module
comprises 6 questions about suicidal ideation and behav-
ior: (1–5) In the past month, did you 1. think you would
be better off dead or wish you were dead? (1 point), 2.
want to harm yourself? (2 points), 3. think about suicide?
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suicide? (10 points). 6. In your life, have you ever made a
suicide attempt? (4 points). The total number of points
is used to classify the current suicide risk on three levels.
Scores ranging from 1 to 5 are considered low risk, from
6 to 9 are moderate, and above 10 are high. According
to the previous study investigating predictive value of
MINI suicidality module, the sensitivity and specificity
for suicide attempts after 12 months in patients with
moderate-risk MINI sum scores are 0.73 and 0.62, and
with high-risk, the MINI sum scores are 0.61 and 0.75
[24]. The positive and negative likelihood ratios for pa-
tients with moderate-risk sum scores are 1.9 (95% CI,
1.1-3.2) and 0.44 (95% CI, 0.26-0.74), respectively, and in
patients with high-risk sum scores, they are 2.4 (95% CI,
1.9-3.0) and 0.52 (95% CI, 0.42-0.65) [24]. In this study,
depression severity was assessed with the Montgomery-
Asberg Depression Rating Scale (MADRS) [25], psychi-
atric symptoms were assessed with the Global Severity
Index(GSI provided by SCL-90-R) [26], fatigue severity
was assessed with the Fatigue Severity Scale (FSS) [27],
health-related quality of life was assessed with the 36
item short form health survey (SF-36) [28], disability
was assessed with the Sheehan Disability Scale (SDS)
[29], and perceived social support was assessed with
the Multidimensional Scale of Perceived Social Support
(MSPSS) [30].
Statistical analysis
Participants were classified as low suicidality (score ≤5
on the MINI suicidality module) or high suicidality
(score ≥6 on the MINI suicidality module). Country, reli-
gion, age group, sex, marital status, work status, and
education were compared across low and high suicidality
groups using Pearson’s chi-square tests. Age, age at first
onset, length of illness, the number of past hospitaliza-
tions, MADRS score, GSI score, FSS score, SF-36’s total
and subscales (bodily pain, emotional wellbeing, general
health, role limitation due to emotional health, role limi-
tation due to physical functioning, social functioning, vi-
tality) score, SDS’s total and subscales (work and school,
social and leisure, family life) score, and MSPSS’s total
and subscales (family, friends, significant others) scores
for low- and high-suicidality groups were compared
using two-tailed Student’s t-tests for normally distributed
variables and Mann–Whitney U-tests for non-normally
distributed variables. A stratified logistic regression model
was used to investigate predictors of high risk of suicide
after controlling for age, sex, years of education, religion,
work status, and total MADRS, GSI, FSS, and MSPSS
scores. To account for collinearity, the country was not in-
cluded as an independent variable but as a stratum in the
stratified logistic regression model, because its association
with other variables such as religion and educationalbackground were high. Independent variables that were
analyzed included age, sex, education, religion, work sta-
tus, history of hospitalization, total MADRS score, GSI of
SCL-90-R score, total FSS score, and total MSPSS score.
Variables significant (p < 0.1) on univariate analysis were
selected for inclusion in the multivariable model.
The null hypothesis was rejected at p < 0.05. The Stat-
istical Package for the Social Sciences (SPSS) software,
version 12.0, and SAS (version 9.3, Cary, NC) were used
for all analyses.
Results
A total of 2,023 outpatients were screened for eligibility,
and 637 (31.5%) were eligible. Of the 637 outpatients
that were eligible, 556 were enrolled in the study. The
remaining 81 outpatients were not enrolled for the follow-
ing reasons: 1) refusal/unwillingness to cooperate (n = 58);
2) insufficient patience to be interviewed (n = 14); or 3) in-
sufficient time to participate (n = 9). All participants were
compensated for their time. The mean (SD) time taken
for completion of the self-administered questionnaires
was 35.8 (14.1) min, and for face-to-face interview was
38.1 (13.8) min. After the interviews, nine participants
were excluded from further analysis because they had no
MDD. The remaining 547 participants were included in
the analysis. 125 (22.9%) were classed as high suicidality
(score ≥6 on the MINI suicidality module) and 422
(77.1%) were classed as low suicidality (score ≤5 on the
MINI suicidality module).
Univariate analysis of sociodemographic and clinical
factors
There were significant differences in country (χ2 = 45.62,
p < 0.001), religion (χ2 = 12.57, p = 0.028), sex (χ2 = 4.13,
p = 0.044), work status (χ2 = 13.42, p = 0.001), and num-
ber of hospitalizations (t = 2.44, p = 0.016) between low
and high suicidality groups (Table 1). The highest pro-
portion of patients classed as high suicidality occurred
in South Korea (42.6%), followed by Taiwan (31.3%),
China (21.9%), and Singapore (17.5%). There were no
significant differences in age, marital status, education,
age at first onset, and length of illness between low and
high suicidality groups (Table 1). The high-suicidality
group had higher MADRS (t = 7.33, p < 0.001), GSI (t =
5.40, p < 0.001), FSS (Z = −3.191, p < 0.001), and SDS scores
(t = 3.34, p = 0.001) and lower SF-36 (t = 5.09, p < 0.001)
and MSPSS scores (t = 3.97, p < 0.001) than did the low-
suicidality group (Table 2).
Multivariate analysis for high suicidality
In the logistic regression model religion, work status,
MADRS score, and FSS scores were related to high suicid-
ality in MDD patients (Table 3). Patients who were un-
employed (adjusted odds ratio (OR) 2.50, 95% confidence
Table 1 Sociodemographic characteristics of major depressive disorder patients with low and high suicidality
Low suicidality (n = 422) High suicidality (n = 125) Comparison of low and high suicidality groups
n % n % χ2 df p value
Country
China 89 78.1 25 21.9 45.62 5 <0.001*
South Korea 58 57.4 43 42.6
Malaysia 82 91.1 8 8.9
Singapore 33 82.5 7 17.5
Thailand 92 89.3 11 10.7
Taiwan 68 68.7 31 31.3
Age group
18–29 years 128 78.5 35 21.5 4.40 4 0.355*
30–39 years 86 71.7 34 28.3
40–49 years 76 74.5 26 25.5
50–59 years 103 81.1 24 18.9
60–65 years 29 82.9 6 17.1
Sex
Male 160 82.1 35 17.9 4.13 1 0.044*
Female 262 74.4 90 25.6
Marital status
Married or co-habiting 254 73.8 64 26.3 2.90 2 0.235
Widowed or divorced 50 79.9 18 20.1
Never married 118 73.5 42 26.5
Work status
Employed 216 84.0 41 16.0 13.42 2 0.001*
Homemaker or student 132 72.1 51 27.9
Unemployed 74 69.2 33 30.8
Education
None or primary 67 83.8 13 16.3 3.30 2 0.192
Secondary or vocational 236 74.7 80 25.3
College 119 78.8 32 21.2
Past hospitalization 13.76 1 .001**
None 394 93.8 104 83.2
Presence 26 6.2 21 16.8
Religion
No religion 159 73.3 58 26.7 12.57 5 0.028*
Buddhist 152 v 39 20.4
Christian 50 69.4 22 30.6
Hindu 20 95.2 1 4.8
Muslim 34 89.5 4 10.5
Other 7 87.5 1 12.5
Mean (SD) Mean (SD) t df p value
Age (years) 39.9 (13.4) 38.7 (12.6) 0.89 545 0.376
Age at first onset (years) 36.9 (13.4) 34.8 (12.8) 1.56 544 0.119
Length of illness (weeks) 76.1 (159.3) 90.2 (174.8) 0.45 545 0.398
*P < 0.05.
**P < 0.01.
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Table 2 Clinical characteristics of major depressive disorder patients with low and high suicidality
Low suicidality (n = 422) High suicidality (n = 125) Comparison of low and high suicidality groups
t or Z df p value
MADRS score 27.78 (7.96) 33.58 (7.14) 7.33 545 <0.001**
GSI (of SCL-90-R) score 0.13 (0.06) 0.17(0.07) 5.40 543 <0.001**
FSS score 4.92 (1.47) 5.42 (1.22) −3.19 236.19 0.001**
SF-36 score 376.7 (124.1) 311.9 (126.8) 5.09 542 <0.001**
Bodily pain† 59.19 (27.22) 55.94 (29.46) −1.04 543 .294
Emotional wellbeing 33.52 (18.15) 24.29 (16.89) 5.05 544 <0.001**
General health 37.15 (20.42) 32.70 (23.06) 2.07 544 0.039*
Role limitation due to
emotional health†
41.45 (26.77) 30.17 (24.95) −4.27 543 <0.001**
Role limitations due to
hysical health†
50.67 (28.73) 42.85 (28.17) −2.70 544 <0.001**
Physical functioning 79.83 (22.37) 69.82 (25.44) −4.14 180.48 <0.001**
Social functioning 46.77 (24.87) 40.02 (25.90) −2.63 544 0.008*
Vitality 28.41 (19.21) 16.63 (15.65) −6.27 242.14 <0.001**
SDS score 16.52 (8.08) 19.22 (7.73) 3.34 545 0.001**
Work/school 6.23 (2.29) 7.34 (2.55) −3.46 203.59 0.001**
Social/leisure 5.64 (3.00) 6.52 (2.84) −2.92 544 0.003**
Family life 5.24 (3.20) 6.35 (2.95) −3.40 543 0.001**
MSPSS score 4.56 (1.40) 3.99 (1.42) 3.97 542 <0.001**
Family 4.89 (1.65) 4.18 (1.87) −3.64 180.60 <0.001**
Friends 4.35 (1.59) 3.85 (1.56) 3.07 542 0.002**
Significant others 4.71 (1.82) 4.18 (1.82) −2.93 542 0.003**
†Reversely-coded variables. Higher score indicates better quality of life.
MADRS, Montgomery-Åsberg Depression Rating Scale; Global Severity Index(SCL-90-R, Symptoms Checklist Questionnaire-90-Revised); FSS, Fatigue Severity Scale;
SF-36, Medical Outcome Survey Short Form-36; SDS, Sheehan Disability Scale; MSPSS, Multidimensional Scale of Perceived Social Support.
*P < 0.05.
**P < 0.01.
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talization(adjusted odds ratio (OR) 2.96, 95% confidence
interval (CI) 1.41-6.20), patients who had high MADRS
score (adjusted OR 1.11, 95% CI 1.07-1.15), and patients
who had a high FSS score (crude OR 1.36, 95% CI 1.15–
1.61) had increased odds of being in the high suicidality
group. The MSPSS score (adjusted OR 0.83, 95% CI 0.70–
0.98) was inversely associated with high suicidality. Age,
sex, years of education, religion, and marital status were
not significant in the model (Table 3).
Discussion
In the current study, MDD patients were categorized as
low or high suicidality according to their score on the
MINI suicidality module. Country, religion, sex, work sta-
tus, depression severity (measured using MADRS), and
the number of past hospitalizations differed between pa-
tients with low and high suicidality, but age, marital status,
education level, age at first onset of MDD, and length of
illness were similar in the two groups. In Malaysia andThailand, about 10% of MDD patients were classed as
high suicidality, whereas in South Korea over 40% of
MDD patients were classed as high suicidality. This is
consistent with recent epidemiological studies on national
suicide rates. The World Health Organization reported
that suicide rates in East Asian countries such as South
Korea and China were much higher than in Malaysia and
Thailand [3], and the prevalence of suicidal behavior has
consistently been reported to be high in South Korea [31].
Differences in the suicide rates in Asian countries are re-
lated to various factors including climate, religion, finan-
cial status, and availability of suicide methods [2]. For
instance, South Korea and China experience more drastic
weather changes than Thailand or Malaysia, and such
changes may contribute to the high suicide rate [32]. Fur-
thermore, the abrupt social changes and economic reces-
sion in East Asian countries is likely to have influenced
the suicide rate.
In the present study, there was a significant relationship
between religion and suicidality. Patients who were Hindu
Table 3 Stratified logistic regression model for high suicidality (stratum: country)
Values Crude OR (95% CI) Wald p value Adjusted OR† (95% CI) Wald p value
Age 0.98 (0.97–1.00) 3.390 0.066 0.99 (0.97–1.01) 1.783 0.182
Sex: Female 1.55 (0.98–2.45) 3.552 0.059 1.36 (0.80–2.30) 1.304 0.254
Education
None or primary 1 2.704 0.259
Secondary or vocational 1.78 (0.89–3.55) 2.651 0.104
College 1.72 (0.81–3.69) 1.976 0.160
Marital status
Married or co-habiting 1 3.487 0.175
Widowed or divorced 1.29 (0.68–2.45) 0.628 0.428
Never married 1.56 (0.97–2.50) 3.406 0.065
Religion
No religion 1 3.259 0.660
Buddhist 1.39 (0.75–2.56) 1.099 0.294
Christian 1.19 (0.61–2.36) 0.262 0.609
Hindu 0.46 (0.05–3.91) 0.511 0.475
Muslim 1.23 (0.33–4.60) 0.097 0.755
Others 0.35 (0.04–2.99) 0.929 0.335
Work status
Employed 1 6.565 0.038 1 7.397 0.025
Homemaker or student 1.60 (0.96–2.66) 3.309 0.069 1.22 (0.69–2.16) 0.452 0.502
Unemployed 2.03 (1.15–3.59) 5.920 0.015 2.54 (1.29–5.01) 7.247 0.007
Past hospitalization
None 1
Presence 3.39 (1.76–6.54) 13.305 <0.001 2.90 (1.38–6.07) 7.948 0.005
MADRS score 1.13 (1.09–1.17) 51.005 <0.001 1.10 (1.06–1.14) 22.354 <0.001
GSI (of SCL-90-R) score 1.11 (1.07–1.15) 30.439 <0.001 1.04 (1.00–1.09) 3.269 0.071
FSS score 1.36 (1.15–1.61) 12.827 <0.001 1.09 (0.90–1.32) 0.813 0.367
MSPSS score 0.78 (0.67–0.91) 9.993 0.002 0.84 (0.71–1.00) 3.748 0.053
OR, odds ratio; CI, confidence interval; MADRS, Montgomery-Åsberg Depression Rating Scale; Global Severity Index (SCL-90-R, Symptoms Checklist Questionnaire-90-Revised
excluding the depression subscale); FSS, Fatigue Severity Scale; MSPSS, Multidimensional Scale of Perceived Social Support.
*P < 0.05.
**P < 0.01.
†Adjusted variables: p < 0.1 in univariate analysis.
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consistent with previous reports that practicing a religion
that forbids suicide, such as Islam, contributes to low sui-
cide rates [2,5]. However, the relationship between religion
and suicidality was not significant after stratifying the effect
of country; thus, no independent effect of religion on
suicidality was evident. There was a higher proportion of
females than males in the high suicidality group [33-36].
Previous studies have revealed higher suicidality in females
in Asian countries than in females in countries such as the
United States and Australia [33-36]. This difference could
be related to the low socioeconomic status of women, pres-
ence of abusive family relationships, and the frequent use
of violent suicide methods in Asian countries [33-36].Unemployed persons had a 2.5 times higher risk of being in
the high suicidality group than employed persons. This
indicates a need for social structural efforts to improve
employment stability in addition to clinical interventions to
lower the suicide rate [37].
The high suicidality group had more severe depression,
indicated by higher MADRS scores, than the low suicidality
group, and reported a greater number of psychiatric. This
corresponds with existing arguments that depression sever-
ity and other comorbid conditions are crucial risk factors
for suicide [9-12,18]. Further, perceived social support,
assessed using the MSPSS, served as a protective factor for
suicidality. According to the present results, patients who
perceived a low level of support from family, friends, and
Lim et al. BMC Psychiatry 2014, 14:37 Page 7 of 8
http://www.biomedcentral.com/1471-244X/14/37significant others had a higher risk of being in the high sui-
cidality group. The importance of social support for suicide
prevention has been suggested many times in previous
studies [9,11,38], and may be particularly important in the
family-oriented Asian culture, where individuals with men-
tal illness have a tendency to be hidden and isolated from
society because the stigma of mental illness affects the en-
tire family [39]. Social support should therefore be regarded
as an important factor for preventing suicide, and interven-
tions based on social relationships should be expanded in
Asian countries. It is interesting that although perceived
social support was a protective factor for suicidality, marital
status had no significant influence on suicidality. Existing
research has shown that marital status or the presence of a
partner is not a protective factor for suicide in Asian coun-
tries because of the characteristics of the family system in
Asian countries [2,40]. Many Asians tend to stay married
due to gender inequalities and the negative perception of
divorce in Asian society, but stressful martial relationships
may worsen depression or increase the suicidality [2,40].
Age [9], education [13], and sex, which have all been
found to be risk factors in previous studies, were not signifi-
cantly related to suicidality in the logistic regression. This
inconsistency may be due to the differences in subject
characteristics, ethnicities and assessment tools. Age effects
could not be detected as they are not linear within the
range of age reported.
It is possible that suicidality was underestimated due to
bias in self-reports, as patients may be embarrassed to admit
suicidal behavior and mental problems. Additionally, the
samples may not have been representative of each country
as a whole, as they comprised clinical samples drawn from
tertiary care centers. Recruitment was biased toward MDD
patients who used health care institutions, and there may be
differences in health care systems among the six countries
that participated in the study. Also, This study was cross-
sectional in design, making it impossible to identify a casual
relationship between the identified risk factors and suicidal-
ity. Specific risk factors that contributed to the national
differences in suicidality risk among MDD patients were not
examined. Finally, while impact of country and religion were
investigated in the present study, influence of ethnicity was
not explored due to homogeneity in terms of ethnicity in
most countries. A recent epidemiological study in Malaysia
(n = 20,552) by Maniam et al. (2013) showed that suicidal
ideation was significantly associated with Indian ethnicity
(especially among those who were Hindu) compared with
Malays and Chinese [41,42]. Further study about the influ-
ence of ethnicity on suicidality may be needed in the clinical
as well as the general population. Despite these limitations,
the present study revealed that a variety of sociodemo-
graphic and clinical factors were associated with high suicid-
ality in MDD patients from six Asian countries. In
particular, as with severity of MDD, non-clinical featuressuch as social support from various sources were found to
be associated with suicidality. This association with cultural
and social factors may explain the limited relationship
between MDD rate and suicidality in Asian countries.
Further, identification of these factors may facilitate the
identification of MDD patients at risk of suicide and the
provision of suicide prevention guidelines.
Conclusion
It is well-known that Asian countries have high suicide rates.
In addition, the profiles of risk and protective factors of
suicide in Asian countries may differ from those of Western
countries. However, comprehensive investigation of the
characteristics of suicide in the countries was relatively few.
This study aimed to examine the sociodemographic and
clinical factors associated with suicidality in MDD patients
from six Asian countries. The high suicidality group was
found to have higher depressive symptoms, general psycho-
pathology and disability scores and lower quality of life and
social support scores than the low suicidality group. More-
over, some religion, unemployment and past psychiatric
hospitalization were associated with high suicidality in
MDD patients in Asian countries. These findings point to
the need for a careful evaluation of the risk factors for the
suicidality in Asian countries. These factors may facilitate
the identification of MDD patients at risk of suicide.
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